Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IPHA Innate Pharma SA

盘前交易 04-02 07:12:19 EDT

1.35

+0.07

+5.47%

最高1.38	最低1.33	成交量1.19万
今开1.33	昨收1.28	日振幅3.65%
总市值1.27亿	流通市值7,995万	总股本9,372万
成交额1.60万	换手率0.02%	流通股本5,922万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IPHA","market":"US","secType":"STK","nameCN":"Innate Pharma SA","latestPrice":1.35,"timestamp":1775073600000,"preClose":1.28,"halted":0,"volume":11901,"delay":0,"changeRate":0.05468750000000005,"floatShares":59223966,"shares":93719323,"eps":-0.643951,"marketStatus":"盘前交易","change":0.07,"latestTime":"04-02 07:12:19 EDT","open":1.33,"high":1.3767,"low":1.33,"amount":16049.590572,"amplitude":0.036484,"askPrice":1.33,"askSize":3650,"bidPrice":1.24,"bidSize":1650,"shortable":3,"etf":0,"ttmEps":-0.643951,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775136600000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1571284800000,"exchange":"NASDAQ","adjPreClose":1.35,"postHourTrading":{"tag":"盘后","latestPrice":1.35,"preClose":1.35,"latestTime":"16:04 EDT","volume":2,"amount":2.7,"timestamp":1775073865333,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.45716480807850635},"requestUrl":"/m/hq/s/IPHA","defaultTab":"news","newsList":[{"id":"2607098493","title":"Innate Pharma盘中异动 快速拉升5.62%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607098493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607098493?lang=zh_cn&edition=full","pubTime":"2026-01-30 00:10","pubTimestamp":1769703024,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日00时10分，Innate Pharma股票出现波动，股价快速上涨5.62%。截至发稿，该股报1.88美元/股，成交量7903股，换手率0.01%，振幅3.37%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.01%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130001024953efb0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130001024953efb0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2572979534","title":"Innate Pharma盘中异动 早盘大幅拉升7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572979534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572979534?lang=zh_cn&edition=full","pubTime":"2025-09-30 21:31","pubTimestamp":1759239065,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日21时31分，Innate Pharma股票出现波动，股价急速上涨7.14%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Scisparc Ltd.、Nanobiotix、Addex Therapeutics Limited涨幅较大，Scisparc Ltd.、Nls Pharmaceutics Ltd.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为810.48%、245.62%、243.77%，振幅较大的相关个股有Pmv Pharmaceuticals, Inc.、Lunai Bioworks Inc.、Bioatla, Inc.，振幅分别为10.00%、8.48%、7.51%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213105a6a88721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930213105a6a88721&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517294332","title":"Innate Pharma盘中异动 急速拉升8.04%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517294332?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185025,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Innate Pharma股票出现异动，股价急速拉升8.04%。截至发稿，该股报2.15美元/股，成交量1.1293万股，换手率0.01%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.00%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223025abe9b021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223025abe9b021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516530629","title":"Innate Pharma盘中异动 下午盘大幅下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516530629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516530629?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:04","pubTimestamp":1740773053,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时04分，Innate Pharma股票出现异动，股价大幅下挫5.32%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3254.22%、592.00%、392.49%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010404139896c05c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010404139896c05c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386234","title":"Innate Pharma盘中异动 大幅拉升5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386234?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:54","pubTimestamp":1740668072,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时54分，Innate Pharma股票出现异动，股价快速拉升5.31%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Quoin Pharmaceuticals Ltd、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为486.33%、98.25%、86.97%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biorestorative Therapies, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为59.93%、30.36%、21.99%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225432a2567fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225432a2567fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514851092","title":"Innate Pharma盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851092?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:35","pubTimestamp":1740580520,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时35分，Innate Pharma股票出现波动，股价急速拉升5.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Immunoprecise Antibodies Ltd.、Channel Therapeutics Corporation涨幅较大，Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为129.63%、96.91%、79.81%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nutriband Inc C/Wts 、Channel Therapeutics Corporation，振幅分别为38.41%、17.13%、16.86%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223521abddedea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223521abddedea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514929090","title":"Innate Pharma盘中异动 早盘快速跳水6.32%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514929090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514929090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493952,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Innate Pharma股票出现异动，股价快速下挫6.32%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为751.55%、467.30%、235.08%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Maze Therapeutics, Inc.，振幅分别为20.51%、14.67%、8.87%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223232a2538724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223232a2538724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514773047","title":"Innate Pharma盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514773047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514773047?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:02","pubTimestamp":1740412977,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时02分，Innate Pharma股票出现异动，股价大幅上涨5.36%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Pepgen Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为237.75%、102.53%、31.18%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为162.04%、55.69%、53.34%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000257962eade6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000257962eade6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512993165","title":"Innate Pharma股价拉升21.13% 市值涨84.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512993165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512993165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:30","pubTimestamp":1739889048,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时30分，Innate Pharma股票出现波动，股价大幅上涨21.13%。截至发稿，该股报2.35美元/股，成交量839.128万股，换手率10.01%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.00%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223048abd3aeb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223048abd3aeb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509172720","title":"Innate Pharma盘中异动 下午盘急速下跌7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509172720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509172720?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:39","pubTimestamp":1738953592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时39分，Innate Pharma股票出现异动，股价快速下跌7.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Nutriband Inc C/Wts 涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为7935.83%、176.87%、126.48%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、54.97%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208023953a23d5758&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208023953a23d5758&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509726892","title":"Innate Pharma盘中异动 大幅拉升5.06%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509726892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509726892?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:35","pubTimestamp":1738852556,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时35分，Innate Pharma股票出现波动，股价大幅上涨5.06%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4192.52%、375.51%、118.10%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Celularity Inc C/Wts 16/07/2026 、Rani Therapeutics Holdings, Inc.，振幅分别为55.65%、27.95%、18.06%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223556987c8f95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223556987c8f95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508507894","title":"Innate Pharma盘中异动 急速拉升14.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508507894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508507894?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679469,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，Innate Pharma股票出现异动，股价大幅上涨14.53%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Azitra Inc、Evaxion Biotech As、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为834.70%、673.24%、185.13%，振幅较大的相关个股有Omega Therapeutics, Inc.、Azitra Inc、Evaxion Biotech As，振幅分别为17.57%、13.82%、8.75%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223109abc227bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223109abc227bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508263341","title":"Innate Pharma盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508263341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508263341?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:27","pubTimestamp":1738603640,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时27分，Innate Pharma股票出现异动，股价快速下跌5.46%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Hcw Biologics Inc.、Invivyd, Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为672.87%、519.86%、458.38%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、102.85%、63.94%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020401272096171597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020401272096171597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507477185","title":"Innate Pharma盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507477185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507477185?lang=zh_cn&edition=full","pubTime":"2025-01-29 03:15","pubTimestamp":1738091745,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日03时15分，Innate Pharma股票出现异动，股价大幅下挫5.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Silexion Therapeutics Corp、Transcode Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Transcode Therapeutics, Inc.、Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为4895.49%、4890.67%、4291.30%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为239.72%、130.75%、122.16%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129031545a232a6db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129031545a232a6db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506330387","title":"Innate Pharma盘中异动 早盘急速拉升6.21%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506330387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506330387?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:31","pubTimestamp":1737988275,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时31分，Innate Pharma股票出现异动，股价急速上涨6.21%。截至发稿，该股报1.88美元/股，成交量27.5319万股，换手率0.33%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.01%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223115abba5f06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223115abba5f06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505861587","title":"Innate Pharma盘中异动 股价大涨5.90%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505861587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505861587?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:50","pubTimestamp":1737730242,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时50分，Innate Pharma股票出现异动，股价快速上涨5.90%。截至发稿，该股报1.77美元/股，成交量3849股，换手率0.00%，振幅1.13%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.34%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242250429872063f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242250429872063f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505204227","title":"Innate Pharma盘中异动 下午盘股价大跌7.80%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505204227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505204227?lang=zh_cn&edition=full","pubTime":"2025-01-24 02:29","pubTimestamp":1737656997,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日02时29分，Innate Pharma股票出现异动，股价快速下跌7.80%。截至发稿，该股报1.63美元/股，成交量1.451万股，换手率0.02%，振幅2.26%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.96%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240229589870e561&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240229589870e561&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503624794","title":"Innate Pharma盘中异动 临近午盘大幅跳水5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503624794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503624794?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:38","pubTimestamp":1736959124,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时38分，Innate Pharma股票出现异动，股价快速跳水5.88%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Aditxt, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为210.92%、173.30%、171.79%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为68.03%、63.21%、61.60%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116003844a2231ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116003844a2231ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503891955","title":"Innate Pharma盘中异动 早盘快速拉升5.08%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503891955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503891955?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:17","pubTimestamp":1736781460,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时17分，Innate Pharma股票出现波动，股价大幅上涨5.08%。Innate Pharma股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为8022.13%、3888.97%、411.78%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.，振幅分别为318.93%、124.54%、106.07%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323174096025c43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323174096025c43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502705180","title":"Innate Pharma盘中异动 股价大跌5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502705180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502705180?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:40","pubTimestamp":1736358012,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时40分，Innate Pharma股票出现波动，股价快速下挫5.91%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3448.63%、599.47%、588.81%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、143.11%、89.00%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109014012aba37509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109014012aba37509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innate-pharma.com/fr","stockEarnings":[{"period":"1week","weight":0.0547},{"period":"1month","weight":-0.1818},{"period":"3month","weight":-0.2286},{"period":"6month","weight":-0.3431},{"period":"1year","weight":-0.2932},{"period":"ytd","weight":-0.2286}],"compareEarnings":[{"period":"1week","weight":-0.0024},{"period":"1month","weight":-0.0454},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0209},{"period":"1year","weight":0.168},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innate Pharma S.A.成立于1999年9月23日，是一家生物技术公司，致力于发现，开发和商业化一流的治疗性抗体，这些抗体旨在利用免疫系统来治疗严重未满足医疗需求的肿瘤适应症。该公司在免疫肿瘤学的研究和开发方面拥有丰富的经验，是了解自然杀伤细胞或NK细胞生物学的先驱。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.022541},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.022389},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.051036},{"month":4,"riseRate":0.571429,"avgChangeRate":0.017188},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.02182},{"month":6,"riseRate":0.5,"avgChangeRate":-0.084495},{"month":7,"riseRate":0.666667,"avgChangeRate":0.050981},{"month":8,"riseRate":0.666667,"avgChangeRate":0.006631},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.030037},{"month":10,"riseRate":0.5,"avgChangeRate":-0.003161},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.013747},{"month":12,"riseRate":0.571429,"avgChangeRate":0.100532}],"exchange":"NASDAQ","name":"Innate Pharma SA","nameEN":"Innate Pharma SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Innate Pharma SA,IPHA,Innate Pharma SA股票,Innate Pharma SA股票老虎,Innate Pharma SA股票老虎国际,Innate Pharma SA行情,Innate Pharma SA股票行情,Innate Pharma SA股价,Innate Pharma SA股市,Innate Pharma SA股票价格,Innate Pharma SA股票交易,Innate Pharma SA股票购买,Innate Pharma SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}